ArticleFrontiers in pharmacology2022

Co-Treatment With Resveratrol and FGF1 Protects Against Acute Liver Toxicity After Doxorubicin Treatment

Xianchou Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.